Re-arming the immune system to be part of the cure
What we do
Traverse harnesses clinically validated technologies to make the immune system part of the cure. We are developing the next generation of first-in-class immunotherapies. Each pipeline product that Traverse acquires is based on a clinically validated platform in an original risk-sharing model with the licensing partner thereby leveraging technical and developmental expertise.
